Comparison
While Selank is a peptide developed in Russia as an anxiolytic and nootropic; in animal models it reduces anxiety-like behavior and modulates immune parameters under stress39, Tirzepatide is approved for type 2 diabetes and obesity, producing larger HbA1c and body-weight reductions than semaglutide in head-to-head trials24.
While Selank works as a synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, that combines a tuftsin fragment with a Pro-Gly-Pro motif and is reported to modulate GABAergic neurotransmission and cytokine balance while being resistant to proteolytic degradation39, Tirzepatide is a 39-amino-acid synthetic peptide primarily based on GIP sequence with C20 fatty diacid conjugation that acts as a dual agonist at GIP and GLP-1 receptors, enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite24.
Selank is 7 amino acids long, whereas Tirzepatide is longer as it has a length of 39 amino acids. Selank is made up of a sequence of Threonine, Lysine, Proline, Arginine, Proline, Glycine, Proline. Tirzepatide is made up of a sequence of sequence data not available in the current dataset.
Selank
Not clearly established in the current dataset.
Tirzepatide
Glucose-dependent insulinotropic polypeptide receptor (GIPR) and GLP-1 receptor (GLP1R) 24
Selank
Not assigned in the current dataset.
Tirzepatide
Not assigned in the current dataset.